General

Showing 1649–1664 of 2270 results

Article: P29 Breast implants: a rare cause of anaplastic large T-cell lymphoma
€3.03 Add to cart
Article: P29 Unravelling the molecular landscape of post-transplant diffuse large B cell lymphoma
€3.03 Add to cart
Article: P29 WHY DO SOME GRAFTS, USED IN RVOT (RIGHT VENTRICULAR OUTFLOW TRACT) REVALVULATION, GET INFECTED AND OTHERS DO NOT?
€3.03 Add to cart
Article: P2X1 ion channels limit the formation of extra-intestinal neutrophil-rich thrombi in acute colitis
€3.03 Add to cart
Article: P2Y ANTAGONISTS
€3.03 Add to cart
Article: P3.01 Hematopoietic progenitor cell count in mobilized peripheral blood by Sysmex XE-2100: added value in clinical practice?
€3.03 Add to cart
Article: P3.01 NGS based HLA-genotyping using 2 reagent kits (Omixon, GenDx) and 3 software applications: NGSengine, Twin and SeqNext-HLA
€3.03 Add to cart
Article: P3.01 SHP2 is required for hematopoietic cell transformation by FIP1L1-PDGFRA
€3.03 Add to cart
Article: P3.02 Autologous Hematopoietic Stem Cell Transplantation in Crohn’s Disease: Results from our first 14 patients
€3.03 Add to cart
Article: P3.02 Bone Marrow Stromal Cell-derived Exosomes Facilitate Multiple Myeloma Cell Survival Through Inhibition of the JNK Pathway
€3.03 Add to cart
Article: P3.02 Ponatinib as bridge to haematopoietic stem cell transplantation in a patient with a myeloid/lymphoid neoplasm with eosinophilia and abnormality of FGFR1: a case report
€3.03 Add to cart
Article: P3.03 Anemia, thrombocytopenia and radiculitis in the setting of allogeneic stem cell transplantation
€3.03 Add to cart
Article: P3.03 High-sensitivity multiparameter flow cytometric analysis for evaluation of bone marrow involvement in systemic mastocytosis
€3.03 Add to cart
Article: P3.03 Study of immune recovery in a randomized phase II trial of sequential double autologous transplantation with unmanipulated or AC133+ PBSC in patients with multiple myeloma
€3.03 Add to cart
Article: P3.04 Effects of tocilizumab® on Th17 cells differentiation in a humanized mouse model of xenogenic graft-versus-host disease
€3.03 Add to cart
Article: P3.04 Epidemiology of patients receiving hematopoietic stem cell patients in Belgium
€3.03 Add to cart

Article: P29 Breast implants: a rare cause of anaplastic large T-cell lymphoma

Article: P29 Unravelling the molecular landscape of post-transplant diffuse large B cell lymphoma

Article: P29 WHY DO SOME GRAFTS, USED IN RVOT (RIGHT VENTRICULAR OUTFLOW TRACT) REVALVULATION, GET INFECTED AND OTHERS DO NOT?

Article: P2X1 ion channels limit the formation of extra-intestinal neutrophil-rich thrombi in acute colitis

Article: P2Y ANTAGONISTS

Article: P3.01 Hematopoietic progenitor cell count in mobilized peripheral blood by Sysmex XE-2100: added value in clinical practice?

Article: P3.01 NGS based HLA-genotyping using 2 reagent kits (Omixon, GenDx) and 3 software applications: NGSengine, Twin and SeqNext-HLA

Article: P3.01 SHP2 is required for hematopoietic cell transformation by FIP1L1-PDGFRA

Article: P3.02 Autologous Hematopoietic Stem Cell Transplantation in Crohn’s Disease: Results from our first 14 patients

Article: P3.02 Bone Marrow Stromal Cell-derived Exosomes Facilitate Multiple Myeloma Cell Survival Through Inhibition of the JNK Pathway

Article: P3.02 Ponatinib as bridge to haematopoietic stem cell transplantation in a patient with a myeloid/lymphoid neoplasm with eosinophilia and abnormality of FGFR1: a case report

Article: P3.03 Anemia, thrombocytopenia and radiculitis in the setting of allogeneic stem cell transplantation

Article: P3.03 High-sensitivity multiparameter flow cytometric analysis for evaluation of bone marrow involvement in systemic mastocytosis

Article: P3.03 Study of immune recovery in a randomized phase II trial of sequential double autologous transplantation with unmanipulated or AC133+ PBSC in patients with multiple myeloma

Article: P3.04 Effects of tocilizumab® on Th17 cells differentiation in a humanized mouse model of xenogenic graft-versus-host disease

Article: P3.04 Epidemiology of patients receiving hematopoietic stem cell patients in Belgium